These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7031707)

  • 1. Nitroimidazole radiosensitizers: approaches to their chemical synthesis.
    Monney H; Parrick J; Wallace RG
    Pharmacol Ther; 1981; 14(2):197-216. PubMed ID: 7031707
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential radiosensitizing agents. 4. 2-Nitroimidazole nucleosides.
    Sakaguchi M; Webb MW; Agrawal KC
    J Med Chem; 1982 Nov; 25(11):1339-42. PubMed ID: 6890579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of novel 2-nitroimidazole-tethered tricyclic quinolines, bearing a second heteroatom, and their in vitro evaluation as hypoxia-selective cytotoxins and radiosensitizers.
    Papadopoulou MV; Rosenzweig HS; Bloomer WD
    Bioorg Med Chem Lett; 2004 Mar; 14(6):1523-5. PubMed ID: 15006395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential radiosensitizing agents. 7. 4(5)-Iodo-5(4)-nitroimidazole derivatives.
    Gupta RP; Larroquette CA; Agrawal KC; Grodkowski J; Neta P
    J Med Chem; 1985 Aug; 28(8):987-91. PubMed ID: 4020837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential radiosensitizing agents. Dinitroimidazoles.
    Agrawal KC; Bears KB; Sehgal RK; Brown JN; Rist PE; Rupp WD
    J Med Chem; 1979 May; 22(5):583-6. PubMed ID: 379334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synthesis of 1-substituted nitroimidazoles and its evaluation as radiosensitizing agents].
    Adams DR; Martul R; Alvarez MV; López Zumel MC; Espada M
    Acta Cient Venez; 1991; 42(5):257-65. PubMed ID: 1843567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis inhibitor TX-1898: syntheses of the enantiomers of sterically diverse haloacetylcarbamoyl-2-nitroimidazole hypoxic cell radiosensitizers.
    Jin CZ; Nagasawa H; Shimamura M; Uto Y; Inayama S; Takeuchi Y; Kirk KL; Hori H
    Bioorg Med Chem; 2004 Sep; 12(18):4917-27. PubMed ID: 15336271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential radiosensitizing agents. 6. 2-Nitroimidazole nucleosides: arabinofuranosyl and hexopyranosyl analogues.
    Sakaguchi M; Larroquette CA; Agrawal KC
    J Med Chem; 1983 Jan; 26(1):20-4. PubMed ID: 6827525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological activity of anti-angiogenic hypoxic cell radiosensitizer haloacetylcarbamoyl-2-nitroimidazoles.
    Hori H; Jin CZ; Kiyono M; Kasai S; Shimamura M; Inayama S
    Bioorg Med Chem; 1997 Mar; 5(3):591-9. PubMed ID: 9113337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-function radiosensitizers. Alpha-[[(2-bromoethyl)amino]methyl]-2-nitro-1H-imidazole-1-ethanol and related compounds: preparation via an aziridine equivalent.
    Suto MJ; Stier MA; Werbel LM
    J Med Chem; 1991 Mar; 34(3):1207-9. PubMed ID: 2002462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, transportability and hypoxiaselective binding of 1-beta-D-(5-Deoxy-5-fluororibofuranosyl)-2-nitroimidazole (beta-5-FAZR), a configurational isomer of the clinical hypoxia marker, FAZA.
    Emami S; Kumar P; Yang J; Kresolic Z; Paproski R; Cass C; McEwan AJ; Wiebe LI
    J Pharm Pharm Sci; 2007; 10(2):237-45. PubMed ID: 17706182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of potential dual-acting radiation sensitizer antineoplastic agents: 2,2-dimethylphosphoraziridines containing 2-nitroimidazoles or other electron-affinic moieties.
    Perlman ME; Dunn JA; Piscitelli TA; Earle J; Rose WC; Wampler GL; MacDiarmid JE; Bardos TJ
    J Med Chem; 1991 Apr; 34(4):1400-7. PubMed ID: 2016716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitroimidazoles, XIV: Synthesis of 4-nitroimidazoles with 1-substituents containing acid, ester or phenol functions, and radiosensitizing efficiency of some of these compounds.
    Suwinski J; Szczepankiewicz W; Widel M
    Arch Pharm (Weinheim); 1992 Jun; 325(6):317-24. PubMed ID: 1444756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of the enantiomers of the bioreductively-activated cytotoxin RSU-1069 and its prodrug RB6145 and lack of stereoselectivity in their cytotoxicity and radiosensitization in vitro.
    Naylor MA; Threadgill MD; Showalter HD; Stratford IJ; Stephens MA; Fielden EM; Adams GE
    Drug Des Discov; 1993; 10(3):249-55. PubMed ID: 8268395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-phenylindole-linked nitroimidazoles as potential radiosensitizers for estrogen receptor positive tumors.
    Erber S; von Angerer E
    Arch Pharm (Weinheim); 1990 Sep; 323(9):591-4. PubMed ID: 2288481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Radiosensitizing Agents III: 2-Nitro-4-acetylimidazole analogs.
    Sehgal RK; Agrawal KC
    J Pharm Sci; 1982 Nov; 71(11):1203-6. PubMed ID: 7175708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New antimetastatic hypoxic cell radiosensitizers: design, synthesis, and biological activities of 2-nitroimidazole-acetamide, TX-1877, and its analogues.
    Kasai S; Nagasawa H; Yamashita M; Masui M; Kuwasaka H; Oshodani T; Uto Y; Inomata T; Oka S; Inayama S; Hori H
    Bioorg Med Chem; 2001 Feb; 9(2):453-64. PubMed ID: 11249137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of a series of 3,5-disubstituted benzisoxazole-4,7-diones. Potent radiosensitizers in vitro.
    Suto MJ; Stier MA; Winters RT; Turner WR; Pinter CD; Elliott WE; Sebolt-Leopold JS
    J Med Chem; 1991 Nov; 34(11):3290-4. PubMed ID: 1956048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electron-affinic radiosensitizers possessing NPSH-reactive side chains: cytotoxicity and radiosensitizing activity towards hypoxic EMT6 cells in vitro.
    Zhou L; Nishimoto S
    Int J Radiat Biol; 1995 Mar; 67(3):335-46. PubMed ID: 7897282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KIH-802: 2-nitroimidazole-1-acetohydroxamate as a hypoxic cell radiosensitizer.
    Hori H; Murayama C; Mori T; Shibamoto Y; Abe M; Onoyama Y; Inayama S
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1029-32. PubMed ID: 2703381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.